Andere Sprachen AtriCure, Inc.

Aktien

A0ES9W

US04963C2098

ATRC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
24.76 ^USD	+2.65%		+7.42%	-30.62%

23.04.	ATRICURE, INC. : Bewertung von Oppenheimer zum Kaufen erhalten	ZM
18.04.	AtriCure, Inc. kündigt Markteinführung der CryoSPHERE®?+ Sonde für die postoperative Schmerzbehandlung an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, vs. Street Est of $106.9M	01.05.
AtriCure: Q1 Earnings Snapshot	01.05.
AtriCure Reports First Quarter 2024 Financial Results	01.05.
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01.05.
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference	30.04.
AtriCure Announces Launch of the cryoSPHERE+ Probe for Post-Operative Pain Management	19.04.
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management	18.04.
AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	18.04.
AtriCure to Announce First Quarter 2024 Financial Results	10.04.
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference	26.03.
AtriCure Insider Sold Shares Worth $307,510, According to a Recent SEC Filing	07.03.
Atricure, Inc. Appoints Shlomi Nachman as Director, Member of Each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee	27.02.
AtriCure Q4 Loss Widens, Revenue Rises; 2024 Guidance Set	15.02.
Earnings Flash (ATRC) ATRICURE Reports Q4 Revenue $106.5M, vs. Street Est of $104.2M	15.02.
AtriCure: Q4 Earnings Snapshot	15.02.
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results	15.02.
Atricure, Inc. Provides Earnings Guidance for 2024	15.02.
AtriCure, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15.02.
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference	25.01.
AtriCure Reports Higher Preliminary Q4, 2023 Revenue; Issues 2024 Revenue Guidance; Shares Rise	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AtriCure, Inc.

Aktien

A0ES9W

US04963C2098

ATRC

Andere Sprachen

Filter